Should O&P Prepare for Value‑Based Care? Part 2
Last week, we looked squarely at the costs of “getting ready” for value-based care in a world that still calls us “parts suppliers” in a fee-for-service world. We talked about outcomes, culture, and relationships—and we acknowledged that all of that takes real time and energy.
Now let’s look at the other side of the ledger.
If you do this work—tighten your processes, start tracking outcomes, and position yourself as an allied health professional instead of a parts vendor—what do you actually get in return?
The short answer: you get benefits in three buckets that matter whether or not formal VBC ever lands in your lap—better clinical insight, a stronger professional identity, and a much sturdier position in an environment that’s watching DMEPOS very closely.
Benefit 1: Better clinical insight and sharper decisions
The first payoff is the least flashy and maybe the most important: you learn from your own data instead of just your gut. When you routinely capture even a small outcomes bundle—say, one functional measure plus a fall risk or safety indicator at baseline and follow-up—you start to see patterns you simply can’t see in individual charts.
Over time, you’ll be able to answer questions like:
For our transtibial patients with similar comorbidities and demographics, what care plans are consistently getting people to community ambulation and in what time period?
Which subsets of our spinal or neuromuscular patients are struggling the most with adherence or falls, and what device or education patterns show up in their charts?
Where are we seeing more repairs, re-dos or adjustment than we’d like, and what’s driving them?
That kind of insight lets you:
Refine your own clinical decisionmaking, so new clinicians don’t have to reinvent the wheel.
Standardize the approaches that work best in your specific population, instead of relying only on manufacturer literature or outside studies.
Have smarter conversations with referral sources: “Here’s what we’re consistently seeing in your patients over 6–12 months, and here’s how we’re adjusting our approach.”
This is where the “VBC prep” effort stops being hypothetical and starts making your everyday practice better—independent of any payer program.
Benefit 2: Stronger professional identity and differentiation
On paper, we’re still living under the DMEPOS umbrella. In spreadsheets, we can look like “expensive devices” alongside a long list of other codes. That’s part of what makes it so easy for outsiders to think of us as vendors first and clinicians second.
A disciplined outcomes and documentation story helps flip that script.
When your charts show:
Face-to-face evaluations and follow-ups that look like clinical encounters, not just measurements for a product,
Device choices clearly linked to patient goals (safety, mobility, return to work) and confirmation of medical necessity,
Outcomes that show how patients are actually doing, not just that a device was delivered,
you look a lot more like an allied health professional managing a complex intervention over time.
That matters in several situations:
When a hospital or system is deciding which partners to bring into multidisciplinary clinics or care pathways.
When a health plan is deciding whether to keep you in a narrow network or funnel more work through a “lowestbidder” arrangement.
When a referring surgeon or PCP is deciding whether to call you to talk through a tricky case or just scribble “AFO” and move on.
You can’t control every decision, but you can make it much harder for reasonable people to treat you as interchangeable with a call-center brace vendor.
Benefit 3: A better shield in a fraud sensitive environment
You’re not running a brace mill. You’re seeing real patients and trying to do the right thing. But the current enforcement climate doesn’t start from your intent— it starts from billing data.
CMS, OIG, and DOJ are looking for patterns: unusual volumes, odd mix of codes, clusters of medically unnecessary orders. They’ve made DMEPOS a very public example of “we’re serious about fraud and abuse.”
That’s where your internal discipline pays off in a very practical way.
When a payer or auditor looks at your practice, you want them to see:
Certified and licensed clinicians documenting assessments, decisions, and follow-up care,
Device use tied to solid indications, not vague “knee pain” or telemarketing scripts,
Results that make sense for your patient mix (for example, patterns similar to what the O&P outcomes literature has shown over 12–18 months).
You can’t prevent every question. But when you’ve taken the time to build clean workflows and a basic outcomes story, it’s much easier to answer those questions with confidence.
In that sense, the time you spend tightening documentation and outcomes isn’t just “VBC prep”—it’s a very practical insurance policy in a world where honest O&P practices don’t want to get lumped in with the worst DME headlines.
Benefit 4: A stronger hand if (and when) VBC arrives
Even if you’re skeptical about how fast value-based models will hit O&P directly, they’re already shaping how your referral sources are managed.
PCPs, surgeons, and health systems are under pressure to:
Avoid preventable readmissions.
Reduce ED visits and postacute facility days.
Show that their referral patterns make sense when someone looks at cost and outcomes over a year or more.
If you can walk into those conversations with a simple, credible story—“Here is what happens to your patients’ mobility and safety when we’re involved, and here’s how that shows up in total cost over time”—you are much more likely to be part of their solution set when they’re asked to trim costs or rethink pathways.
That doesn’t mean you volunteer to take risk tomorrow. It just means that if and when a local ACO, health system, or MA plan says, “We’re redesigning this episode,” you are already positioned as the O&P partner who understands their world and can back it up with data.
Putting it together: is it worth it?
So, back to the original question:
If the future is uncertain, should prosthetists and orthotists invest in outcomes tracking, reputation building, and deeper clinical partnerships now—or sit tight and wait?
When you factor in:
The costs we talked about in Part 1: time, workflow change, culture work, and some focused communication effort;
The benefits we’ve just walked through: better insight, stronger identity, a practical compliance shield, and a more powerful story in any future VBC or contracting conversations;
the balance tilts toward intentional, incremental change.
Not a giant, high risk transformation. Not a pivot into becoming a “VBC shop.” Just a deliberate decision that:
You want your charts and your data to match the level of clinical work you actually do.
You want to be seen—and treated—as an allied health partner in your community.
You’d rather make small, proactive moves now than scramble later under someone else’s timeline.
In the next series, we’ll talk about how to make those moves without burning people out or falling into the classic innovation traps leaders in every industry warn about—trying to “transform” on top of already full plates, chasing tools without clear goals, and undercommunicating change.
For now, if these two posts did their job, you don’t have to be convinced that change is coming. You just have to be convinced that building better habits around outcomes, identity, and partnership is a good bet for your practice—no matter what the payment models decide to call themselves next year.
Next week I will continue with “From Intent to Execution” -- a practical roadmap for modernizing your practice without burning out your team or falling for “innovation theater.” We’ll show you how to pick one high‑impact goal, design a pilot that fits real O&P life, avoid the classic leadership mistakes experts warn about, and turn small wins into a stronger position with referrers and payers. If you’re ready to move from talk to action, this series is your playbook.